Mesoblast MESO
NASDAQ MESO
$17.32 +0.18 (+1.05%)
At close: Sep 4, 2026 · 4:00 PM EDT

Mesoblast (MESO) Total Debt (2018 - 2026)

Mesoblast (MESO) posted Total Debt of -$82.6 million for Q4 2025, down 136.01% sequentially from $229.3 million in Q2 2025, and down 116.89% YoY from $488.8 million in Q4 2024.

Analysis

Mesoblast (MESO) Total Debt (2018 - 2026) Analysis & Trends

Mesoblast has reported Total Debt for 8 years, with the latest figure at -$82.6 million in Q4 2025.

  • Quarterly Total Debt fell 116.89% year-over-year to -$82.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$82.6 million (down 116.89% YoY) and the FY2025 annual result came in at $229.3 million, up 100.52% from the prior year.
  • Total Debt fell to -$82.6 million in Q4 2025 per MESO's latest filing, from $229.3 million in the prior quarter.
  • Over five years, Total Debt peaked at $229.3 million in Q2 2025 and troughed at -$82.6 million in Q4 2025.
  • A 5-year average of $76.1 million and a median of $94.2 million in 2021 frame the typical range for Total Debt.
  • The sharpest annual moves came in 2022 and 2024: Total Debt jumped 341.66% in 2022, then slumped 141.53% in 2024.
  • Over 5 years, Total Debt stood at $173.1 million in 2021, then plunged by 110.82% to -$18.7 million in 2022, then gained by 15.85% to -$15.8 million in 2023, then plunged by 141.53% to -$38.1 million in 2024, then slumped by 116.89% to -$82.6 million in 2025.
  • According to Business Quant data, Total Debt over the past three periods registered -$82.6 million, $229.3 million, and -$38.1 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.99 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 591.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.07 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 9.34 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 546.77 Mn
10 Mesoblast 2.24 Bn 2.14 Bn - 10.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.60 Mn
Dec 31, 2025 66.74 Mn
Jun 30, 2025 54.16 Mn
Dec 31, 2024 17.51 Mn
Jun 30, 2024 13.86 Mn
Dec 31, 2023 8.53 Mn
Jun 30, 2023 5.95 Mn
Mar 31, 2023 7.31 Mn
Dec 31, 2022 5.94 Mn
Sep 30, 2022 5.49 Mn
Jun 30, 2022 5.02 Mn
Mar 31, 2022 5.52 Mn
Dec 31, 2021 5.20 Mn
Sep 30, 2021 53.85 Mn
Jun 30, 2021 53.20 Mn
Mar 31, 2021 52.67 Mn
Dec 31, 2020 41.57 Mn
Sep 30, 2020 34.89 Mn
Jun 30, 2020 32.46 Mn
Mar 31, 2020 27.00 Mn